FDA calls on companies to end marketing of unapproved suppositories
The FDA today asked five drugmakers to end the manufacturing and marketing of suppository drug products containing trimethobenzamide hydrochloride, due ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.